Reference
HCPCS J-codes for specialty drugs
182 HCPCS J-codes for outpatient infusion + injection drug billing. Each shows the generic + brand names, FDA indication, and common denial patterns.
Codes indexed
182
| Code | Generic | Brand(s) |
|---|---|---|
| J0129 | abatacept | Orencia |
| J0135 | adalimumab | Humira, Amjevita, Cyltezo, Hadlima, Hyrimoz, Hulio, Yusimry, Idacio, Yuflyma |
| J0178 | aflibercept | Eylea |
| J0179 | brolucizumab | Beovu |
| J0180 | faricimab | Vabysmo |
| J0223 | givosiran | Givlaari |
| J0401 | aripiprazole long-acting | Abilify Maintena |
| J0490 | belimumab | Benlysta |
| J0517 | benralizumab | Fasenra |
| J0570 | buprenorphine implant | Probuphine |
| J0571 | buprenorphine extended-release | Sublocade |
| J0584 | burosumab-twza | Crysvita |
| J0585 | onabotulinumtoxinA | Botox |
| J0586 | abobotulinumtoxinA | Dysport |
| J0587 | rimabotulinumtoxinB | Myobloc |
| J0588 | incobotulinumtoxinA | Xeomin |
| J0591 | deoxycholic acid | Kybella |
| J0640 | leucovorin | |
| J0717 | certolizumab pegol | Cimzia |
| J0742 | imipenem cilastatin and relebactam | Recarbrio |
| J0791 | crizanlizumab-tmca | Adakveo |
| J0881 | darbepoetin alfa | Aranesp |
| J0882 | darbepoetin alfa | Aranesp |
| J0883 | argatroban | |
| J0885 | epoetin alfa | Epogen, Procrit |
| J0886 | epoetin alfa | Epogen, Procrit |
| J0897 | denosumab | Prolia, Xgeva |
| J1300 | eculizumab | Soliris |
| J1322 | elosulfase alfa | Vimizim |
| J1325 | epoprostenol | Flolan, Veletri |
| J1428 | eteplirsen | Exondys 51 |
| J1437 | ferumoxytol | Feraheme |
| J1438 | etanercept | Enbrel |
| J1439 | iron sucrose | Venofer |
| J1442 | filgrastim | Neupogen |
| J1447 | tbo-filgrastim | Granix |
| J1452 | fomivirsen | Vitravene (withdrawn) |
| J1555 | immune globulin (Cuvitru) | Cuvitru |
| J1556 | immune globulin Bivigam | Bivigam |
| J1557 | immune globulin IV Gammaplex | Gammaplex |
| J1559 | immune globulin Hizentra | Hizentra |
| J1561 | immune globulin (Gamunex) | Gamunex-C, Gammaked |
| J1566 | immune globulin lyophilized | Gammagard S/D |
| J1568 | immune globulin (Octagam) | Octagam |
| J1569 | immune globulin (Gammagard) | Gammagard |
| J1571 | hepatitis B immune globulin | HepaGam B |
| J1572 | immune globulin (Flebogamma) | Flebogamma DIF |
| J1599 | immune globulin NOC | |
| J1602 | golimumab | Simponi, Simponi Aria |
| J1640 | hemin | Panhematin |
| J1644 | heparin | |
| J1650 | enoxaparin | Lovenox |
| J1652 | fondaparinux | Arixtra |
| J1745 | infliximab | Remicade |
| J1750 | iron dextran | INFeD, Dexferrum |
| J1756 | iron sucrose | Venofer |
| J1815 | insulin | |
| J1817 | insulin lispro | Humalog, Admelog |
| J1885 | ketorolac | Toradol |
| J1930 | lanreotide | Somatuline Depot |
| J1931 | laronidase | Aldurazyme |
| J1953 | levetiracetam | Keppra |
| J2182 | mepolizumab | Nucala |
| J2270 | morphine sulfate | |
| J2315 | naltrexone XR | Vivitrol |
| J2323 | natalizumab | Tysabri |
| J2326 | nusinersen | Spinraza |
| J2350 | ocrelizumab | Ocrevus |
| J2354 | octreotide | Sandostatin |
| J2355 | octreotide | Sandostatin |
| J2357 | omalizumab | Xolair |
| J2358 | olanzapine long-acting | Zyprexa Relprevv |
| J2358-alt | olanzapine LAI | Zyprexa Relprevv |
| J2426 | paliperidone palmitate | Invega Sustenna, Invega Trinza, Invega Hafyera |
| J2469 | palonosetron | Aloxi |
| J2503 | pegaptanib | Macugen |
| J2505 | pegfilgrastim | Neulasta |
| J2562 | plerixafor | Mozobil |
| J2680 | fluphenazine decanoate | |
| J2680b | haloperidol decanoate | Haldol Decanoate |
| J2778 | ranibizumab | Lucentis |
| J2779 | ranibizumab biosimilar | Cimerli, Byooviz |
| J2786 | reslizumab | Cinqair |
| J2792 | rho-immune-globulin | RhoGAM, WinRho |
| J2941 | somatropin | Genotropin, Humatrope, Norditropin, Nutropin, Saizen, Serostim, Zomacton |
| J3032 | eptinezumab-jjmr | Vyepti |
| J3060 | taliglucerase alfa | Elelyso |
| J3245 | tildrakizumab-asmn | Ilumya |
| J3262 | tocilizumab | Actemra |
| J3299 | triamcinolone acetonide (Triesence) | Triesence |
| J3304 | triamcinolone acetonide PF | Triesence, Trivaris |
| J3357 | ustekinumab | Stelara |
| J3358 | ustekinumab IV | Stelara |
| J3380 | vedolizumab | Entyvio |
| J3385 | velaglucerase alfa | VPRIV |
| J3488 | ibandronate | Boniva |
| J3489 | zoledronic acid | Zometa, Reclast |
| J3490 | unclassified drugs | |
| J3590 | unclassified biologics | |
| J7178 | factor VIII recombinant | Advate, Kovaltry, Nuwiq, Eloctate |
| J7180 | factor XIII concentrate | Corifact |
| J7185 | antihemophilic factor recombinant | |
| J7187 | humate-P | Humate-P |
| J7188 | factor VIIa | NovoSeven RT |
| J7189 | factor VIIa long-acting | Sevenfact |
| J7190 | factor VIII | |
| J7191 | factor VIII porcine | Obizur |
| J7193 | factor IX | BeneFIX, Alprolix, Rixubis |
| J7195 | factor IX recombinant | |
| J7199 | hemophilic clotting factor NOC | |
| J7300 | intrauterine copper contraceptive | ParaGard |
| J7307 | etonogestrel implant | Nexplanon |
| J7311 | fluocinolone intravitreal implant | Retisert |
| J7312 | dexamethasone intravitreal implant | Ozurdex |
| J7321 | hyaluronan or derivative (Hyalgan/Supartz) | Hyalgan, Supartz |
| J7322 | hyaluronic acid Synvisc-One | Synvisc, Synvisc-One |
| J7323 | hyaluronan or derivative (Euflexxa) | Euflexxa |
| J7324 | hyaluronan or derivative (Orthovisc) | Orthovisc |
| J7325 | hyaluronan or derivative (Synvisc) | Synvisc, Synvisc-One |
| J7327 | hyaluronan or derivative (Monovisc) | Monovisc |
| J7330 | autologous cultured chondrocytes | Carticel, MACI |
| J7345 | aminolevulinic acid HCl | Levulan Kerastick |
| J7500 | azathioprine, oral | Imuran |
| J7505 | muromonab-CD3 | |
| J7515 | cyclosporine, oral | Sandimmune, Neoral |
| J7517 | mycophenolate mofetil | CellCept |
| J7525 | tacrolimus, parenteral | Prograf |
| J7527 | everolimus oral | Afinitor, Zortress |
| J7607 | levalbuterol inhalation solution | Xopenex |
| J7613 | albuterol inhalation solution | |
| J7626 | budesonide inhalation suspension | Pulmicort |
| J7639 | dornase alfa inhalation solution | Pulmozyme |
| J7686 | treprostinil inhalation | Tyvaso |
| J9000 | doxorubicin | Adriamycin |
| J9023 | atezolizumab | Tecentriq |
| J9035 | bevacizumab | Avastin |
| J9039 | blinatumomab | Blincyto |
| J9040 | bleomycin | Blenoxane |
| J9041 | bortezomib | Velcade |
| J9042 | brentuximab vedotin | Adcetris |
| J9045 | carboplatin | |
| J9047 | carfilzomib | Kyprolis |
| J9055 | cetuximab | Erbitux |
| J9070 | cyclophosphamide | Cytoxan |
| J9100 | cytarabine | |
| J9144 | daratumumab SC | Darzalex Faspro |
| J9145 | daratumumab | Darzalex |
| J9171 | docetaxel | Taxotere |
| J9173 | durvalumab | Imfinzi |
| J9201 | gemcitabine | Gemzar |
| J9202 | goserelin acetate | Zoladex |
| J9203 | gemtuzumab ozogamicin | Mylotarg |
| J9217 | leuprolide acetate suspension | Lupron Depot |
| J9226 | histrelin | Supprelin, Vantas |
| J9228 | ipilimumab | Yervoy |
| J9229 | inotuzumab ozogamicin | Besponsa |
| J9259 | paclitaxel protein-bound | Abraxane |
| J9261 | nelarabine | Arranon |
| J9263 | oxaliplatin | Eloxatin |
| J9264 | paclitaxel protein-bound | Abraxane |
| J9266 | pegaspargase | Oncaspar |
| J9267 | paclitaxel | Taxol |
| J9271 | pembrolizumab | Keytruda |
| J9290 | obinutuzumab | Gazyva |
| J9293 | tisagenlecleucel | Kymriah |
| J9299 | nivolumab | Opdivo |
| J9301 | obinutuzumab | Gazyva |
| J9305 | pemetrexed | Alimta |
| J9306 | pertuzumab | Perjeta |
| J9310 | rituximab | Rituxan |
| J9311 | rituximab + hyaluronidase | Rituxan Hycela |
| J9312 | rituximab (biosimilar) — Truxima | Truxima |
| J9355 | trastuzumab | Herceptin |
| J9358 | fam-trastuzumab deruxtecan | Enhertu |
| J9358-alt | fam-trastuzumab | Enhertu |
| J9395 | fulvestrant | Faslodex |
| J9999 | unclassified antineoplastic | |
| Q2034 | influenza Afluria | |
| Q2035 | influenza Agriflu | |
| Q2036 | influenza FluLaval | |
| Q2037 | influenza Fluvirin | |
| Q2039 | influenza vaccine NOC |
Contact: hello@approvalhelp.com